TransCode Therapeutics, Inc. - Nilai bisnis marang pendapatan RNAZ

Logo perusahaan publik TransCode (RNAZ)

Is it worth investing in cancer RNA therapy from TransCode Therapeutics (RNAZ) given the potential of the TTX-MS138 platform? The EV/Sales trajectory will help determine a sustainable valuation range, with 0.00 representing the latest metric reading. Success depends on the efficiency of nanoparticle delivery into tumors, while risks are tied to high capital expenditure in the absence of sales.

TransCode Therapeutics, Inc. (RNAZ): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 19.11.2026

RNAZ (TransCode Therapeutics): rincian analitis lan laporan miturut indikator

- rincian nilai pasar emiten:
Pambiji fundamental perusahaan:RNAZ, TransCode Therapeutics
Produk seri TransCode

To protect capital, investors assess the risk of overpayment by analyzing the ratio of enterprise value to annual revenue, excluding the impact of leverage. In the context of the development of the RNA therapy TTX-MS138, the TransCode Therapeutics (RNAZ) value-to-revenue trend reflects market expectations for future licensing deals, where an increase in this metric signals an overvaluation relative to current operational efficiency.

Pesaing langsung

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|Phio Pharmaceuticals - Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Mustang Bio, Inc. (MBIO)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan